Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2012, Article ID 787305, 3 pages
http://dx.doi.org/10.1155/2012/787305
Case Report

Clinical Challenges in the Management of Leishmania/HIV Coinfection in a Nonendemic Area: A Case Report

1Division of Immunology, Allergy and Infectious Diseases, Department of Dermatology, Medical University of Vienna, 1090 Vienna, Austria
2Department of Infectious Diseases and Tropical Medicine, Medical University of Vienna, 1090 Vienna, Austria
3Department of Dermatology and Venereology, Rudolfstiftung Hospital, 1030 Vienna, Austria

Received 1 November 2012; Accepted 5 December 2012

Academic Editors: L. M. Bush, M. Ghate, P. Horrocks, A. C. Sena, and E. M. Stringer

Copyright © 2012 K. Grabmeier-Pfistershammer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Health Organization, http://www.who.int/leishmaniasis/burden/hiv_coinfection/burden_hiv_coinfection/en/index.html.
  2. W. Poeppl, H. Herkner, S. Tobudic et al., “Seroprevalence and asymptomatic carriage of Leishmania spp. in Austria, a non-endemic European country,” Clinical Microbiology and Infection, 2012. In press. View at Publisher · View at Google Scholar
  3. P. D. Ready, “Leishmaniasis emergence in Europe,” Euro Surveillance, vol. 15, no. 10, article 19505, 2010. View at Google Scholar · View at Scopus
  4. S. L. Croft and P. Olliaro, “Leishmaniasis chemotherapy—challenges and opportunities,” Clinical Microbiology and Infection, vol. 17, pp. 1478–1483, 2011. View at Google Scholar
  5. J. Rybniker, V. Goede, J. Mertens et al., “Treatment of visceral leishmaniasis with intravenous pentamidine and oral fluconazole in an HIV-positive patient with chronic renal failure—a case report and brief review of the literature,” International Journal of Infectious Diseases, vol. 14, no. 6, pp. e522–e525, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Cruz, J. Nieto, J. Moreno, C. Cañavate, P. Desjeux, and J. Alvar, “Leishmania/HIV co-infections in the second decade,” Indian Journal of Medical Research, vol. 123, no. 3, pp. 357–388, 2006. View at Google Scholar · View at Scopus
  7. G. F. Cota, M. R. de Sousa, F. N. Demarqui, and A. Rabello, “The diagnostic accuracy of serologic and molecular methods for detecting visceral leishmaniasis in HIV infected patients: meta analysis,” PLOS Neglected Tropical Diseases, vol. 6, no. 5, Article ID e1665, 2012. View at Google Scholar
  8. R. Ter Horst, S. M. Collin, K. Ritmeijer, A. Bogale, and R. N. Davidson, “Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome,” Clinical Infectious Diseases, vol. 46, no. 11, pp. 1702–1709, 2008. View at Publisher · View at Google Scholar · View at Scopus
  9. R. López-Vélez, “The impact of highly active antiretroviral therapy (HAART) on visceral leishmaniasis in Spanish patients who are co-infected with HIV,” Annals of Tropical Medicine and Parasitology, vol. 97, pp. S143–S147, 2003. View at Google Scholar
  10. S. Sundar, J. Chakravarty, D. Agarwal, M. Rai, and H. W. Murray, “Single-dose liposomal amphotericin B for visceral leishmaniasis in India,” New England Journal of Medicine, vol. 362, no. 6, pp. 504–512, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. P. K. Sinha, J. van Griensven, K. Pandey et al., “Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India,” Clinical Infectious Diseases, vol. 53, no. 7, pp. e91–e98, 2011. View at Google Scholar
  12. G. F. Cota, M. R. de Sousa, and A. Rabello, “Predictors of visceral leishmaniasis relapse in hiv-infected patients: a systematic review,” PLoS Neglected Tropical Diseases, vol. 5, no. 6, Article ID e1153, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Lachaud, N. Bourgeois, M. Plourde, P. Leprohon, P. Bastien, and M. Ouellette, “Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum,” Clinical Infectious Diseases, vol. 48, no. 2, pp. e16–e22, 2009. View at Publisher · View at Google Scholar · View at Scopus